N-Fmoc-2,6-dimethyl-L-tyrosine is a non-proteinogenic, protected amino acid derivative. Its structure features an L-tyrosine backbone with methyl groups at the 2- and 6-positions of the aromatic ring and an N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group. This compound is a specialized building block primarily used in solid-phase peptide synthesis (SPPS) employing the Fmoc strategy. The dimethyl substitution on the tyrosine phenol ring significantly alters the steric and electronic properties of the amino acid side chain. This modification is introduced to enhance the metabolic stability, lipophilicity, and receptor binding affinity of synthetic peptides, making it a valuable tool in the development of peptide-based pharmaceuticals and research probes. As a high-purity, protected amino acid, it is a critical intermediate for constructing peptides with tailored biological activities. Its use is common in medicinal chemistry and biochemical research for creating analogs of bioactive peptides, such as opioid receptor ligands or enzyme inhibitors, where modulating the properties of tyrosine residues is required.